Tech Company Financing Transactions

Hydra Biosciences Funding Round

Hydra Biosciences closed a $22 million Series D funding round on 1/16/2009. Investors included MedImmune Ventures, Abingworth and Advanced Technology Ventures.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

45 Moulton St.
Cambridge, MA 02138
USA

Phone

(617) 494-5230

Website

www.hydrabiosciences.com

Email Address

[email protected]

Overview

Hydra Biosciences is committed to developing novel drugs to treat important human diseases in major therapeutic areas using its expertise in ion channels and regeneration

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Russell Herndon

        

Vice President

Bert Chenard

        

Vice President

Magdalene Moran

        

VP - Finance

Tom Burke

        

Browse more venture capital transactions:

Prev: 1/16/2009: EvoOrganic venture capital transaction
Next: 1/16/2009: Zeo venture capital transaction

Share this article

Where The Data Comes From

We do our best to document funding rounds that are announced publicly. All VC database entries reported here are derived from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary